From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

VINDICATED yet again: Advanced Oncotherapy – is that the Fat lady I hear at the doorstep? Companies House filing…

By Tom Winnifrith, the Sheriff of AIM | Wednesday 15 May 2024

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Slung off the AIM Casino more than five months after it should have been, no cash, borrowings and other liabilities of £60 million, no refinancing no accounts since H1 2022, Advanced Oncotherapy (AVO) looks like a dead duck, walks like a dead duck and quacks like a dead duck. And….
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



Ariana – Surprise!

Time left: 02:52:39